Skip to menu Skip to content Skip to footer

2024

Journal Article

Pituitary tumours without distinct lineage differentiation express stem cell marker SOX2

Lenders, Nèle F., Thompson, Tanya J., Chui, Jeanie, Low, Julia, Inder, Warrick J., Earls, Peter E. and McCormack, Ann I. (2024). Pituitary tumours without distinct lineage differentiation express stem cell marker SOX2. Pituitary, 27 (3), 248-258. doi: 10.1007/s11102-024-01385-0

Pituitary tumours without distinct lineage differentiation express stem cell marker SOX2

2024

Journal Article

The glucocorticoid receptor: isoforms, functions, and contribution to glucocorticoid sensitivity

Lockett, Jack, Inder, Warrick J and Clifton, Vicki L (2024). The glucocorticoid receptor: isoforms, functions, and contribution to glucocorticoid sensitivity. Endocrine Reviews, 45 (4), 593-624. doi: 10.1210/endrev/bnae008

The glucocorticoid receptor: isoforms, functions, and contribution to glucocorticoid sensitivity

2024

Journal Article

Testosterone treatment, weight loss and health-related quality of life and psychosocial function in men: a two-year RCT

Grossmann, Mathis, Robledo, Kristy P, Daniel, Mark, Handelsman, David J, Inder, Warrick J, Stuckey, Bronwyn G A, Yeap, Bu B, Ng Tang Fui, Mark, Bracken, Karen, Allan, Carolyn A, Jesudason, David, Zajac, Jeffrey D and Wittert, Gary A (2024). Testosterone treatment, weight loss and health-related quality of life and psychosocial function in men: a two-year RCT. The Journal of Clinical Endocrinology & Metabolism, 109 (8), 2019-2028. doi: 10.1210/clinem/dgae085

Testosterone treatment, weight loss and health-related quality of life and psychosocial function in men: a two-year RCT

2024

Journal Article

Long-term outcomes of testosterone treatment in men: A T4DM post-randomisation observational follow-up study

Handelsman, David J., Grossmann, Mathis, Yeap, Bu B., Stuckey, Bronwyn G. A., Shankara-Narayana, Nandini, Conway, Ann J., Inder, Warrick J., McLachlan, Robert I., Allan, Carolyn, Jenkins, Alicia J., Jesudason, David, Bracken, Karen and Wittert, Gary A. (2024). Long-term outcomes of testosterone treatment in men: A T4DM post-randomisation observational follow-up study. The Journal of Clinical Endocrinology and Metabolism, 109 (1), e25-e31. doi: 10.1210/clinem/dgad485

Long-term outcomes of testosterone treatment in men: A T4DM post-randomisation observational follow-up study

2023

Journal Article

Elevated insulin‐like growth factor‐1 in patients without clinical evidence of acromegaly

Careless, Laura, Inder, Warrick J., Pretorius, Carel and Hayes, Lisa (2023). Elevated insulin‐like growth factor‐1 in patients without clinical evidence of acromegaly. Clinical Endocrinology, 99 (3), 296-305. doi: 10.1111/cen.14917

Elevated insulin‐like growth factor‐1 in patients without clinical evidence of acromegaly

2023

Journal Article

Obesity and ‘functional hypogonadism’ – mechanisms and management: Commentary on EJE-22-1110 “Leflutrozole in Male Obesity-Associated Hypogonadotropic Hypogonadism: Ph 2b Double-Blind RCT”

Inder, Warrick J and Grossmann, Mathis (2023). Obesity and ‘functional hypogonadism’ – mechanisms and management: Commentary on EJE-22-1110 “Leflutrozole in Male Obesity-Associated Hypogonadotropic Hypogonadism: Ph 2b Double-Blind RCT”. European Journal of Endocrinology, 189 (3), R7-R9. doi: 10.1093/ejendo/lvad100

Obesity and ‘functional hypogonadism’ – mechanisms and management: Commentary on EJE-22-1110 “Leflutrozole in Male Obesity-Associated Hypogonadotropic Hypogonadism: Ph 2b Double-Blind RCT”

2023

Journal Article

Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the Testosterone for Prevention of Type 2 Diabetes Mellitus trial

Robledo, Kristy P., Marschner, Ian C., Handelsman, David J., Bracken, Karen, Stuckey, Bronwyn G A, Yeap, Bu B., Inder, Warrick, Grossmann, Mathis, Jesudason, David, Allan, Carolyn A. and Wittert, Gary (2023). Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the Testosterone for Prevention of Type 2 Diabetes Mellitus trial. European Journal of Endocrinology, 188 (7), 613-620. doi: 10.1093/ejendo/lvad074

Mediation analysis of the testosterone treatment effect to prevent type 2 diabetes in the Testosterone for Prevention of Type 2 Diabetes Mellitus trial

2023

Journal Article

The evolution in pituitary tumour classification: a clinical perspective

Lenders, Nele F., Earls, Peter E., Inder, Warrick J. and McCormack, Ann I. (2023). The evolution in pituitary tumour classification: a clinical perspective. Endocrine Oncology, 3 (1) e220079, 1-13. doi: 10.1530/eo-22-0079

The evolution in pituitary tumour classification: a clinical perspective

2023

Journal Article

Pituitary tumours: molecular and genetic aspects

De Sousa, Sunita M. C., Lenders, Nele F., Lamb, Lydia, Inder, Warrick J. and McCormack, Ann I. (2023). Pituitary tumours: molecular and genetic aspects. Journal of Endocrinology, 257 (3) e220291, 1-16. doi: 10.1530/joe-22-0291

Pituitary tumours: molecular and genetic aspects

2023

Journal Article

Approach to the patient – disorders of salt and water balance post pituitary surgery

Brooks, Emily K. and Inder, Warrick J. (2023). Approach to the patient – disorders of salt and water balance post pituitary surgery. The Journal of Clinical Endocrinology and Metabolism, 108 (1), 198-208. doi: 10.1210/clinem/dgac622

Approach to the patient – disorders of salt and water balance post pituitary surgery

2022

Journal Article

Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours

Lenders, N. F., Chui, J., Low, J., Inder, W. J., Earls, P. E. and McCormack, A. I. (2022). Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours. Pituitary, 25 (6), 1-7. doi: 10.1007/s11102-022-01284-2

Development of a cost-effective diagnostic algorithm incorporating transcription factor immunohistochemistry in the evaluation of pituitary tumours

2022

Journal Article

Treatment of prolactinoma

Inder, Warrick J. and Jang, Christina (2022). Treatment of prolactinoma. Medicina (Kaunas, Lithuania), 58 (8) 1095, 1095. doi: 10.3390/medicina58081095

Treatment of prolactinoma

2022

Journal Article

Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injections

Handelsman, David J., Desai, Reena, Conway, Ann J., Shankara-Narayana, Nandini, Stuckey, Bronwyn G. A., Inder, Warrick J., Grossmann, Mathis, Yeap, Bu Beng, Jesudason, David, Ly, Lam P., Bracken, Karen and Wittert, Gary Allen (2022). Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injections. European Journal of Endocrinology, 186 (3), 307-318. doi: 10.1530/EJE-21-0608

Recovery of male reproductive endocrine function after ceasing prolonged testosterone undecanoate injections

2021

Journal Article

Impact of subclinical hypothyroidism on health-related quality of life: a narrative review

Danicic, Joseph M., Inder, Warrick J. and Kotowicz, Mark A. (2021). Impact of subclinical hypothyroidism on health-related quality of life: a narrative review. Internal Medicine Journal, 51 (9), 1380-1387. doi: 10.1111/imj.15431

Impact of subclinical hypothyroidism on health-related quality of life: a narrative review

2021

Journal Article

Effect of testosterone treatment on bone microarchitecture and bone mineral density in men: a 2-year RCT

Ng Tang Fui, Mark, Hoermann, Rudolf, Bracken, Karen, Handelsman, David J., Inder, Warrick J., Stuckey, Bronwyn G. A., Yeap, Bu B., Ghasem-Zadeh, Ali, Robledo, Kristy P., Jesudason, David, Zajac, Jeffrey D., Wittert, Gary A. and Grossmann, Mathis (2021). Effect of testosterone treatment on bone microarchitecture and bone mineral density in men: a 2-year RCT. Journal of Clinical Endocrinology and Metabolism, 106 (8), E3143-E3158. doi: 10.1210/clinem/dgab149

Effect of testosterone treatment on bone microarchitecture and bone mineral density in men: a 2-year RCT

2021

Journal Article

Ex vivo glucocorticoid-induced secreted proteome approach for discovery of glucocorticoid-responsive proteins in human serum

Inder, Warrick J., Mohamed, Ahmed, Keshvari, Sahar, Barclay, Johanna L., Ruelcke, Jayde E., Stoll, Thomas, Nolan, Brendan J., Cesana-Nigro, Nicole and Hill, Michelle M. (2021). Ex vivo glucocorticoid-induced secreted proteome approach for discovery of glucocorticoid-responsive proteins in human serum. Proteomics - Clinical Applications, 15 (2-3) 2000078, 2000078. doi: 10.1002/prca.202000078

Ex vivo glucocorticoid-induced secreted proteome approach for discovery of glucocorticoid-responsive proteins in human serum

2021

Journal Article

Copeptin is increased by nausea and vomiting during hypertonic saline infusion in healthy individuals

Brooks, Emily, Bachmeier, Caroline, Vorster, Juanita, Sorbello, Jane, Peer, Faseeha, Chikani, Viral, Dimeski, Goce, Ungerer, Jacobus, Pretorius, Carel and Inder, Warrick (2021). Copeptin is increased by nausea and vomiting during hypertonic saline infusion in healthy individuals. Clinical Endocrinology, 94 (5), 820-826. doi: 10.1111/cen.14417

Copeptin is increased by nausea and vomiting during hypertonic saline infusion in healthy individuals

2021

Journal Article

The relationship between early post‐operative ACTH / cortisol following pituitary surgery and long‐term glucocorticoid requirement – Do ultradian rhythms matter?

English, Katherine A., Chikani, Viral, Jang, Christina, Dimeski, Goce, Olson, Sarah and Inder, Warrick J. (2021). The relationship between early post‐operative ACTH / cortisol following pituitary surgery and long‐term glucocorticoid requirement – Do ultradian rhythms matter?. Clinical Endocrinology, 94 (4), 636-644. doi: 10.1111/cen.14404

The relationship between early post‐operative ACTH / cortisol following pituitary surgery and long‐term glucocorticoid requirement – Do ultradian rhythms matter?

2021

Journal Article

Towards precision medicine for clinically non-functioning pituitary tumours

Lenders, Nèle F., Inder, Warrick J. and McCormack, Ann I. (2021). Towards precision medicine for clinically non-functioning pituitary tumours. Clinical Endocrinology, 95 (3), 398-409. doi: 10.1111/cen.14472

Towards precision medicine for clinically non-functioning pituitary tumours

2021

Journal Article

Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial

Wittert, Gary, Bracken, Karen, Robledo, Kristy P, Grossmann, Mathis, Yeap, Bu B, Handelsman, David J, Stuckey, Bronwyn, Conway, Ann, Inder, Warrick, McLachlan, Robert, Allan, Carolyn, Jesudason, David, Fui, Mark Ng Tang, Hague, Wendy, Jenkins, Alicia, Daniel, Mark, Gebski, Val and Keech, Anthony (2021). Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial. The Lancet Diabetes and Endocrinology, 9 (1), 32-45. doi: 10.1016/S2213-8587(20)30367-3

Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial